Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Berkels

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Human Genetics|May 28, 2003
Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)Andreas Lazar, Dirk Gründemann, Reinhard Berkels, et al.
Pharmacology|October 13, 2005
Antioxidant and nitric oxide-sparing actions of dihydropyridines and ACE inhibitors differ in human endothelial cellsHeinrich Lob, Anke Claudia Rosenkranz, Thomas Breitenbach, et al.
Parkinsonism & Related Disorders|January 18, 2015
Reduction of gastrointestinal symptoms in Parkinson's disease after a switch from oral therapy to rotigotine transdermal patch: a non-interventional prospective multicenter trialDirk Woitalla, Jan Kassubek, Lars Timmermann, et al.
Vascular Pharmacology|April 12, 2005
Different antioxidative potencies of dihydropyridine calcium channel modulators in various modelsReinhard Berkels, Thomas Breitenbach, Henning Bartels, et al.
Journal of Cardiovascular Pharmacology|September 10, 2003
The HMG-CoA reductase inhibitor cerivastatin enhances the nitric oxide bioavailability of the endotheliumReinhard Berkels, Sepideh Khajeh Nouri, Dirk Taubert, et al.
Current Medical Research and Opinion|March 17, 2015
Caregivers' and physicians' attitudes to rotigotine transdermal patch versus oral Parkinson's disease medication: an observational studyJörn Peter Sieb, Peter Themann, Tobias Warnecke, et al.
Free Radical Biology & Medicine|December 19, 2003
Reaction rate constants of superoxide scavenging by plant antioxidantsDirk Taubert, Thomas Breitenbach, Andreas Lazar, et al.
Sleep Medicine|February 21, 2016
Management of augmentation of restless legs syndrome with rotigotine: a 1-year observational studyClaudia Trenkwalder, Monica Canelo, Michael Lang, et al.
Sleep Medicine|May 15, 2013
Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in GermanyKarin Stiasny-Kolster, Daniela Berg, Werner E Hofmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2005
Discovery of the ergothioneine transporterDirk Gründemann, Stephanie Harlfinger, Stefan Golz, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Human Genetics|May 28, 2003
Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)Andreas Lazar, Dirk Gründemann, Reinhard Berkels, et al.
Pharmacology|October 13, 2005
Antioxidant and nitric oxide-sparing actions of dihydropyridines and ACE inhibitors differ in human endothelial cellsHeinrich Lob, Anke Claudia Rosenkranz, Thomas Breitenbach, et al.
Parkinsonism & Related Disorders|January 18, 2015
Reduction of gastrointestinal symptoms in Parkinson's disease after a switch from oral therapy to rotigotine transdermal patch: a non-interventional prospective multicenter trialDirk Woitalla, Jan Kassubek, Lars Timmermann, et al.
Vascular Pharmacology|April 12, 2005
Different antioxidative potencies of dihydropyridine calcium channel modulators in various modelsReinhard Berkels, Thomas Breitenbach, Henning Bartels, et al.
Journal of Cardiovascular Pharmacology|September 10, 2003
The HMG-CoA reductase inhibitor cerivastatin enhances the nitric oxide bioavailability of the endotheliumReinhard Berkels, Sepideh Khajeh Nouri, Dirk Taubert, et al.
Current Medical Research and Opinion|March 17, 2015
Caregivers' and physicians' attitudes to rotigotine transdermal patch versus oral Parkinson's disease medication: an observational studyJörn Peter Sieb, Peter Themann, Tobias Warnecke, et al.
Free Radical Biology & Medicine|December 19, 2003
Reaction rate constants of superoxide scavenging by plant antioxidantsDirk Taubert, Thomas Breitenbach, Andreas Lazar, et al.
Sleep Medicine|February 21, 2016
Management of augmentation of restless legs syndrome with rotigotine: a 1-year observational studyClaudia Trenkwalder, Monica Canelo, Michael Lang, et al.
Sleep Medicine|May 15, 2013
Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in GermanyKarin Stiasny-Kolster, Daniela Berg, Werner E Hofmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2005
Discovery of the ergothioneine transporterDirk Gründemann, Stephanie Harlfinger, Stefan Golz, et al.
Pageof 3